barbican: ipatasertib plus atezolizumab and chemotherapy in tnbc
Published 3 years ago • 138 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
5:01
keynote-522: final os findings of pembrolizumab and chemotherapy in tnbc
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
4:49
adding atezolizumab to adjuvant chemotherapy for stage ii and iii triple-negative breast cancer ...
-
0:54
oncology appointments for metastatic triple negative breast cancer #tnbc #breast cancer #radiation
-
1:07
neotrip: efs in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk tnbc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
0:47
atezolizumab for tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
3:13
atezolizumab in metastatic tnbc: long-term clinical outcomes and biomarker analyses
-
12:38
triple-negative breast cancer (tnbc): everything you need to know
-
1:20
pathfinder: ipatasertib with non-taxane chemotherapy in patients with atnbc
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
2:05
treatment advances in tnbc
-
1:48
residual tumor treatment in mutant brca-1 triple-negative breast cancer